Skip to main content
    E

    enGene Holdings Inc. Common Stock (ENGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.71
    +0.15 (+9.62%)

    Market Cap: $106.42M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(6/11)
    Avg Surprise
    +12.95%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Oct 31, 2026
    EPS Consensus$-0.34
    Range$-0.42 - $-0.24
    9 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Jan 31, 2027
    EPS Consensus$-0.34
    Range$-0.39 - $-0.30
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.52+35.0%
    60d ago$-0.31-10.9%
    30d ago$-0.31-10.9%
    7d ago$-0.31-10.9%
    Current$-0.34
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jan 27EST
    		-$-0.34---
    Oct 26EST
    		-$-0.34---
    Jul 26
    Reported Sep 8
    		$0.47$-0.44+206.82%Beat+182.5%
    Apr 26
    Reported Jun 15
    		$-0.43$-0.48+10.42%Beat+15.7%
    Jan 26
    Reported Mar 9
    		$-0.44$-0.57+23.32%Beat+8.3%
    Oct 25
    Reported Dec 22
    		$-0.73$-0.58-25.86%Miss-114.7%
    Jul 25
    Reported Sep 10
    		$-0.57$-0.51-11.76%Miss-78.1%
    Apr 25
    Reported Jun 12
    		$-0.51$-0.48-6.25%Miss-34.2%
    Jan 25
    Reported Mar 10
    		$-0.48$-0.37-29.73%Miss-4.3%
    Oct 24
    Reported Dec 19
    		$-0.34$-0.36+5.56%Beat+92.5%
    Jul 24
    Reported Sep 10
    		$-0.32$-0.35+8.57%Beat-10222.6%
    Apr 24
    Reported Jun 14
    		$-0.38$-0.27-40.74%Miss-121.8%
    Jan 24
    Reported Mar 11
    		$-0.46$-0.47+2.13%Beat-1250.0%
    Oct 23
    Reported Jan 29
    		$-4.51N/AN/ABeat-11609.9%
    Jul 23
    Reported Jul 31
    		$-0.00N/AN/ABeat+84.5%
    Apr 23
    Reported Jun 30
    		$-0.17N/AN/ABeat-471.0%
    Jan 23
    Reported Apr 30
    		$0.04N/AN/ABeat+500.0%
    Oct 22
    Reported Nov 10
    		$0.04N/AN/ABeat-
    Jul 22
    Reported Aug 11
    		$-0.02N/AN/ABeat-
    Apr 22
    Reported May 13
    		$-0.03N/AN/ABeat-
    Jan 22
    Reported Apr 30
    		$-0.01N/AN/ABeat-
    Oct 21
    Reported Dec 30
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.51EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-60.50%ROIC-42.15%
    Financial Health
    Debt/Equity0.11xInterest Coverage-38.34x
    Current Ratio10.21xQuick Ratio10.21x
    Trading Statistics
    Beta-0.28Avg Volume795.18K
    52-Week High$12.2552-Week Low$1.40

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.75
    SMA 20$1.86
    SMA 50$1.84
    SMA 200$4.76
    EMA 10$1.74
    EMA 20$1.80
    EMA 50$1.90
    EMA 200$3.62

    MACD

    Line: -0.06Signal: -0.03Hist: -0.03

    ADX

    ADX: 25.8+DI: 21.0-DI: 31.3

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down96.0
    PSAR$1.92

    Bollinger Bands

    Upper Band$2.14
    Lower Band$1.58
    %B Position3018%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    42.6

    Momentum Oscillators

    Stoch %K11.7
    Stoch %D7.0
    Williams %R-67.4
    ROC (10d)-13.6%
    Momentum-0.27
    CCI (20d)-106.8
    MFI (14d)29.3

    Volatility Measures

    ATR (14d)$0.09(5.2%)
    StdDev (20d)0.14
    Hist Vol56.6%(High)

    Volume Flow

    VWAP$1.68
    OBV17.8M
    AD Line-47.2M
    CMF (20d)0.057

    Volume Metrics

    Avg Vol (20d)813.9K
    Vol Ratio1.4x
    VWMA (20d)$1.86

    Pivot Points

    R3$1.66
    R2$1.64
    R1$1.60
    Pivot Point$1.58
    S1$1.54
    S2$1.52
    S3$1.48

    Advanced Oscillators

    TSI-18.04
    Ultimate Osc43.9
    KST-42.30

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$0$0$0$0$0$0$0$480,000$0$0$0$0
    Cost of Revenue$0$0$0$171,000$0$0$0N/A$0$0$0N/A
    Gross Profit$0$0$0$-171,000$0$0$0$240,000$0$0$0N/A
    Operating Expenses$34.01M$31.97M$31.18M$39.48M$29.95M$27.12M$26.61M$17.45M$16.76M$17.31M$10.77M$10.44M
    R&D$20.09M$22.20M$22.25M$31.72M$22.57M$20.21M$19.97M$11.27M$11.55M$9.86M$5.64M$5.67M
    SG&A$13.92M$9.77M$8.93M$10.02M$7.37M$6.92M$6.64M$6.18M$5.21M$7.46M$5.13M$4.77M
    Operating Income$-34,014,000$-31,968,000$-31,185,000$-39,481,000$-29,947,000$-27,124,000$-26,613,000$-17,455,000$-16,759,000$-17,310,000$-10,773,000$-10,442,000
    Interest Income$2.40M$2.66M$2.74M$1.98M$2.23M$2.49M$2.73M$3.02M$3.38M$2.98M$1.02M$407,000
    Interest Expense$843,000$745,000$1.22M$750,000$758,000$734,000$752,000$756,000$751,000$728,000$929,000$1.16M
    Income Before Tax$-32,501,000$-30,227,000$-29,752,000$-38,377,000$-28,752,000$-25,575,000$-24,598,000$-15,280,000$-14,177,000$-14,963,000$-10,741,000$-82,480,000
    Income Tax Expense$0$0$0$-497,000$239,000$240,000$18,000$19,000$-29,000$21,000$-30,000$17,000
    Net Income$-32,501,000$-30,227,000$-29,752,000$-37,880,000$-28,991,000$-25,815,000$-24,616,000$-15,299,000$-14,148,000$-14,984,000$-10,711,000$-82,497,000
    EBITDA$-34,161,000$-32,282,000$-31,587,000$-37,456,000$-30,765,000$-28,213,000$-27,293,000$-17,372,000$-16,724,000$-17,141,000$-10,757,000$-81,679,000
    EBIT$-34,059,000$-31,968,000$-31,185,000$-37,627,000$-30,227,000$-27,124,000$-26,613,000$-17,455,000$-16,806,000$-17,219,000$-10,837,000$-81,728,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ENGN

    News

    enGene Reports Full Year 2023 Financial Results and Recent Operational Progress

    enGene Holdings Inc. announced its full-year 2023 financial results and provided a corporate update, highlighting significant progress in its lead program, EG-70...

    Lelezard•10/6/26•Bullish

    Engene Holdings stock rating maintained at Market Perform by Citizens

    Citizens has reiterated a "Market Perform" rating on Engene Holdings (NASDAQ: ENGN) after the company reported its Q3 2026 update. Engene Holdings is trading at a significant discount to its cash reserves...

    Investing.com Nigeria•9/9/26•Somewhat-Bearish

    Engene Holdings stock rating maintained at Market Perform by Citizens

    Citizens maintained a "Market Perform" rating on Engene Holdings (NASDAQ:ENGN). The firm noted that Engene Holdings reported a third-quarter 2026 update and highlighted the company's valuation...

    Investing.com•9/9/26•Somewhat-Bearish

    Engene Holdings stock rating maintained at Market Perform by Citizens

    Citizens maintained a Market Perform rating on Engene Holdings (NASDAQ:ENGN) after the company provided a third-quarter 2026 update. The firm discussed Engene's view on the non-muscle invasive bladder cancer market...

    Investing.com India•9/9/26•Neutral

    Engene Holdings stock rating maintained at Market Perform by Citizens

    Citizens has reiterated a Market Perform rating on Engene Holdings Inc. (NASDAQ:ENGN) following the company's Q3 2026 update...

    Investing.com Canada•9/9/26•Neutral

    ENGN Valuation and Fair Value

    P/E
    -1.5x
    P/B
    0.5x
    See GNG's fair value

    ENGN Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -42.2%
    ROE
    -60.5%

    ENGN Competitors

    CompanyTicker
    LENZ Therapeutics IncLENZ
    Stereotaxis IncSTXS
    Tonix Pharmaceuticals Holding CorpTNXP
    Genelux Corporation Common StockGNLX
    Foghorn Therapeutics IncFHTX
    Definitive Healthcare CorpDH
    Cellectis SACLLS
    Vivani Medical Inc.VANI

    Sector: Healthcare

    ENGN Analyst Ratings

    Consensus
    Hold
    Analysts
    10
    Strong Buy
    1
    Buy
    2
    Hold
    6
    Sell
    1
    Strong Sell
    0

    ENGN Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    21.6%
    EPS estimate (fiscal period ending Oct 31, 2026)
    $-0.34

    Frequently Asked Questions About ENGN

    Does ENGN pay dividends?

    enGene Holdings Inc. Common Stock (ENGN) does not currently pay a regular dividend.

    What is ENGN's market cap?

    enGene Holdings Inc. Common Stock (ENGN) has a market capitalization of $106.42M with a current stock price of $1.71.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In